Data-Led Suzuki-Miyaura Reaction Optimization: Development of a Short Course for Postgraduate Synthetic Chemists
A two-day workshop activity is described in which postgraduate students are introduced to (i) the theory and application of Design-of-Experiments (DOE) approaches and (ii) the implementation of affordable automation technologies and related data analysis of a system of catalytic interest. This work involved the design and delivery of a short lecture to introduce the theory of DOE followed by practical demonstrations of the application of automation technologies. Specifically, a fractional factorial design was used to interrogate the input space-base, solvent, temperature, time-of the Suzuki-Miyaura cross-coupling (SMCC) of <i>para</i>-bromoanisole and <i>para</i>-fluorophenylboronic acid using automated solid and liquid handling robots and online HPLC analysis. This was supplemented by a second lecture following data acquisition in which the collected HPLC data was analyzed. The workshop was delivered to a cohort of 15 students at the postgraduate level. Pleasingly, students demonstrated a high degree of engagement with this course structure and reported an increased theoretical understanding of DOE approaches to reaction optimization.
Authors
- Barnabas A. Franklin (ORCID: https://orcid.org/0009-0004-6149-9156)
- Peter O’Brien (ORCID: https://orcid.org/0000-0002-9966-1962)
- Christopher S. Horbaczewskyj (ORCID: https://orcid.org/0000-0003-2393-0246)
- Ian J. S. Fairlamb (ORCID: https://orcid.org/0000-0002-7555-2761)
- Jacob J. Walder (ORCID: https://orcid.org/0000-0002-7024-3193)
- Stuart C. Smith (ORCID: https://orcid.org/0000-0001-7149-0463)
- James D’Souza Metcalf (ORCID: https://orcid.org/0000-0002-0912-2894)
Institutions
- University of York (GB)
Publication Details
- Journal
- Journal of Chemical Education
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1021/acs.jchemed.4c01194
- Citations
- 1
- Primary Topic
- Catalytic Cross-Coupling Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- AstraZeneca
- GlaxoSmithKline
- University of York
- Royal Society
- Engineering and Physical Sciences Research Council